SCLC

Oct 04, 2024

7 Companies at the Forefront of Trispecific Antibody Development

Mar 17, 2023

Immuno-Oncology (I-O) Therapeutics: The Key to Future Cancer Treatment

Sep 06, 2022

AstraZeneca’s Imfinzi for Biliary Tract Cancer; FDA Clears Boehringer’s Spesolimab; Novo Nordisk to Acquire Forma Therapeutics; Sanofi’s Xenpozyme Approved for ASMD; Another FDA Approval to Azurity’s Konvomep; Amgen’s Lumakras Trial Results; FDA Grants Priority Review to Sanofi & Sobi’s efanesoctocog alfa; Neurocrine Bio to Takeover UK Biotech Diurnal

Mar 14, 2022

Small Cell Lung Cancer Treatment Market Propels Due to Extremely Robust Pipeline

Jul 03, 2020

Small Cell Lung Cancer Market Booms with an Influx of Companies and Robust Pipeline

Jul 01, 2020

Top 5 Cancers Creating Major Challenge To The Global Healthcare System

Oct 11, 2018

Copiktra receives approval; Lilly wins approval; Eisai’s Fycompa; Astellas’ Roxadustat; Janssen’s Esketamine Nasal Spray

Newsletter/Whitepaper